Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Continuation Study of the Effects of TRx0014 30 mg TID and 60 mg TID in Patients With Alzheimer's Disease

NCT00684944 is registered in ClinicalTrials.gov with TauRx Therapeutics Ltd as lead sponsor.

NCT NCT00684944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00684944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Continuation Study of the Effects of TRx0014 30 mg TID and 60 mg TID in Patients With Alzheimer's Disease
Lead sponsor
TauRx Therapeutics Ltd
Phase
Phase 2
Overall status
Completed
Start date
September 13, 2007
Completion date
December 2, 2010
Enrollment
111 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease